Fairvalue-Calculator Fairvalue-Calculator
EN DE

G&E Herbal Biotechnology Co (4911) Fair Value & Analysis

Healthcare · TW · Market cap 2.0B TWD

Price31.10 TWD
Fair Value41.39 TWD
Upside+33.1%
Quality95/100
Evidence: High Range 20.61 TWD – 54.61 TWD

Fair value as of: Jun 24, 2026

Analysis

G&E Herbal Biotechnology Co (4911) currently trades at 31.10 TWD, while our model-based Fair Value estimate is 41.39 TWD — implying the stock looks roughly 33.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

G&E Herbal Biotechnology Co., Ltd. engages in manufacturing and wholesale of western and chinese medicine, cosmetics, intellectual property rights, biotechnology services, medical device, and other unclassified food products in Taiwan. It offers HepaGent capsules, a liver protective agent; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -27% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is G&E Herbal Biotechnology Co (4911) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 41.39 TWD versus a price of 31.10 TWD — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 4911?
Our 21-model fair value for G&E Herbal Biotechnology Co is 41.39 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 31.10 TWD.
What is the quality score of 4911?
G&E Herbal Biotechnology Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.